|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
7.500 +0.050 (+0.671%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 49.45 RMB (cts) | |
| Net Profit | 581.44 RMB (MIL) | DPS | 24.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 608.35 | 51.50 | 27.00 | -- | 629.70 | 587.00 |
| 2026 | 680.10 | 57.50 | 30.00 | -- | 709.20 | 651.00 |
| 2027 | 781.60 | 67.00 | 0 | -- | 781.60 | 781.60 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 587.00 | 49.00 | -- | CITIC SEC | Buy | 12.00 | 19/03/2025 | |
| 2025 | 629.70 | 54.00 | 27.00 | GOLDMAN SACHS | Buy | 9.70 | 25/03/2025 | |
| 2026 | 651.00 | 54.00 | -- | CITIC SEC | -- | -- | 19/03/2025 | |
| 2026 | 709.20 | 61.00 | 30.00 | GOLDMAN SACHS | -- | -- | 25/03/2025 | |
| 2027 | 781.60 | 67.00 | -- | GOLDMAN SACHS | -- | -- | 25/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 30/04/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 581,438 |
| %Change | 15.360% |
| EPS / (LPS) | RMB 0.495 |
| NBV Per Share (¥) | RMB 2.175 |